510(k) device
Felix NeuroAI System
Fasikl Incorporated · External Upper Limb Tremor Stimulator (QBC, Class II) · First FDA decision Jul 1, 2025, newest Jul 1, 2025Essential tremor
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "Felix NeuroAI"
MAUDE reports
0
Brand "Felix NeuroAI", since 2015
PubMed studies
0
Mentioning "Felix NeuroAI"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Felix NeuroAI System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Felix NeuroAI System510(k)
K250096 · Decided Jul 1, 2025 · 168 days after receipt
Device type: External Upper Limb Tremor Stimulator (QBC) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- External Upper Limb Tremor Stimulator TherapyLocal determinationIn effectL39591CGS Administrators, LLCUpdated Feb 16, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Felix NeuroAI", any status and sponsor, newest update first.
- Assessment of the Safety and Efficacy of the Felix NeuroAI Wristband in Essential TremorPivotal-lookingCompleted
Fasikl Inc.Not on our public-company list
NCT06235190 · 125 participants · Start Feb 27, 2024 · Primary completion Oct 31, 2024
Device: Felix NeuroAI Wristband; Sham Device · For: Essential Tremor
Sites: Phoenix, Arizona; Palo Alto, California; Boca Raton, Florida · 12 sites in all
Fasikl Inc.Not on our public-company list
NCT05842434 · 38 participants · Start Jun 6, 2023 · Primary completion Nov 29, 2023
Device: Felix NeuroAI Wristband · For: Essential Tremor; Parkinson Disease
Sites: Boca Raton, Florida; Kansas City, Kansas
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Felix NeuroAI", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QBC
6 reports: 0 malfunction, 6 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Felix NeuroAI"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QBC.
- Cala kIQCala Health, Inc. · 510(k) 2025
- Cala kIQ PlusCala Health, Inc. · 510(k) 2026
- Encora X1Encora, Inc. · 510(k) 2026
- Cala TrioCala Health, Inc. · 510(k) 2021
- External upper limb tremor stimulatorCala Health, Inc. · 510(k) 2018
- Cala ONECala Health, Inc. · De Novo 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.